Publications, Reports and Books
2012
E. Langer, Pharmaceutical Online, August 2012
E. Langer, Pharmaceutical Outsourcing, July 2012 PDF
E. Langer, Genetic Engineering News, July 2012 PDF
E. Langer, Life Science Leader, July 2012 PDF
E. Langer, Pharmaceutical Online, June 2012
E. Langer, BioPharm International, June 2012 Special Issue PDF
E. Langer, BioProcess International, May 2012 PDF
E. Langer, Pharmaceutical Online, May 2012 PDF
E. Langer, Genetic Engineering News, May 2012 PDF
Eric Langer, BIO, May 3, 2012
E. Langer, Pharmaceutical Online, March 2012 PDF
E. Langer, Life Science Leader, March 2012 PDF
E. Langer, BioPharm International, March 2012 Special Issue PDF
Eric Lanager, Pharmaceutical Processing, Feb 2012
E. Langer, Life Science Leader, February 2012 PDF
E. Langer, Pharmaceutical Online, February 2012 PDF
Ron Rader and Eric Langer, BioProcess International, February 2012 PDF
E. Langer, Pharmaceutical Technology, February 2012
Eric Langer, BIO, January 12, 2012
> 2011
-
Limited Analytical Technologies Are Inhibiting Industry Growth
E. Langer, October 2011 - Top 1000 Global Biomanufacturing Facilities- Insights from
real-time ranking of global biomanufacturing capabilities.
E. Langer, BioPharmInternational, August 2011 - Can Outsourcing GMP Operations to China Really Work?
E. Langer, Life Science Leader, August 2011 - Single Use Bioreactors Lead in New Use and Market Penetration
E. Langer, Pharma IQ, August 2011 - High Tech Single Use Devices, Bioreactors Lead in Market Penetration
E. Langer, Pharma IQ, August 2011 - Single Use Devices—What’s REALLY Holding Up Adoption?
E. Langer, Life Science Leader, July 2011 - Positive Trends in Biomanufacturing Budgets: Biopharma and Vendor Budgets Are Up
For the First Time in Three Years;
E. Langer, BioProcessing Journal, July 2011 - Hiring In Biopharma — Where Are The Jobs Going Next?
E. Langer, Life Science Leader, July 2011 - Bio-Outsourcing On the Rise: Fewer companies go 100% in-house
E. Langer, Contract Pharma, June 2011 - Will Perfusion Be the Next Revolution in Bioprocessing?
E. Langer, BioProcess International, June 2011 - Offshoring Biomanufacturing: China rises to the top as a destination for international outsourcing
E. Langer, BioProcess International, June 2011 - Biomanufacturing Budget Bump—2011’s Spending Upswing
E. Langer, PharmaIQ, June 2011 - Top 1000 Biomanufacturing Facilities: Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.
E. Langer, BioPharm International, June 2011 - Trends in Biopharmaceutical Industry: Budgets Returning...Investing In Innovation...Productivity & Cost Control
E. Langer, Pharmaceutical Manufacturing, June 2011 - China Ranked Top Potential Biopharma Outsourcing Destination
E. Langer, BioProcess International, June 2011 - Biotech Budgets: Whose Departments Are Winning?
E. Langer, Life Science Leader, June 2011 - Biopharma Wants Better Upstream Bioprocessing Technologies
E. Langer, Pharmaceutical Technology, May 2011 - Downstream Process Bottlenecks: Industry Demanding Better Technologies
E. Langer, Genetic Engineering News, May 2011 - Hiring Trends in Biopharma
E. Langer, Ashton Tweed, May 2011 - Time to Build ‘Relationship’ into the Outsourcing Process
E. Langer (BioData Points), Life Science Leader, May 2011 - Single Use Technologies Changing the Biomanufacturing Landscape
E. Langer, Life Science Leader, May 2011 - Single Use Trends Boosting Adoption or Vendor Satiasfaction
E. Langer, Pharmaceutical Manufacturing, May 2011 - New Plant Expression Systems Drive Vaccine Innovation and Opportunity
E. Langer, BioProcess International, April 2011 - Productivity Bottlenecks Drive the Demand for Innovation
E. Langer, BioProcess International, March 2011 - Improved Downstream Technologies Are Needed to Boost Single-Use Adoption
E. Langer, BioProcess International, March 2011 - Single-Use Products in BioManufacturing: Innovations Driving the Industry
E. Langer, BioProcess International, March 2011 - Need for Access to Enabling Technologies Drives Growth in the Contract Biomanufacturing Market
Hosted by Andrea Charles, PharmaIQ, March 21, 2011 - Biopharmas Doubling Critical Outsourcing Operations; Genetic Engineering News
E. Langer, Genetic Engineering News, February 2011 - Changes Underway for Biopharmaceutical Outsourcing
More crucial biomanufacturing operations are expected to be outsourced
E. Langer, Genetic Engineering News, February 2011 - Changes Underway for Biopharmaceutical Outsourcing
More crucial biomanufacturing operations are expected to be outsourced
E. Langer, Pharmaceutical Technology, February 2011 - European Biomanufacturing Efficiency Outstripping US: Outlook for Capacity Utilisation Through 2015
E. Langer, European Biopharmaceutical Review, January 2011 - Biofuels: Road to Recovery, D Mousdale, BioFuels Intl Dec 2010
D. Mousdale, BioFuels International, January 2011 - E Langer Presents 2011 Trends for Life Science Leader Journal
E. Langer, Life Science Leader Journal, January 2011 - Can Biofuels Recover From the Crunch?
D. Mousdale, BioFpr Journal/Wylie, January 2011
> 2010
- Biofuels: Road to Recovery [160k]
D. Mousdale, BioFuels International, December 2010 - European Biomanufacturing Efficiency Outstripping US: Outlook for Capacity Utilisation Through 2015
E. Langer, European Biopharmaceutical Review, January 2011 - Has Big Oil Finally Embraced Biofuels? [246k]
D. Mousdale, BioFuels International, November 1, 2010 - Outsourcing Winners in 2014: Post recession and beyond
E. Langer, Pharmaceutical Technology, Nov 2, 2010, pp. 112, 115 - Trends to Watch in the Biopharmaceutical Industry [262k]
E. Langer, Pharmaceutical Executive, Supplement for Nov. 2010 - Regulatory Challenges Impede Adoption of new Downstream Technologies
E. Langer, BioPharm International, October 2010 - Plant Expression Systems Growing Rapidly, Vaccines Manufacturers Leading the Way [33k]
E. Langer, Genetic Engineering News, October 15, 2010 - Downstream Disposables: The Missing Link in the Disposables Chain: Acceptance in has been slow.
E. Langer, BioPharm International, August 1, 2010 - Project Managers Wanted: Relationship management is a limiting factor to growth in biomanufacturing outsourcing
E. Langer, Pharmaceutical Technology, Aug 2, 2010, pp. 70, 72 - Perfusion Bioreactors Are Making a Comeback, But Industry Misperceptions Persist [5.6mb]
E. Langer, BioProcessing Journal, Summer 2010 - Managing the Client-Contractor Relationship Increased bio/pharmaceutical outsourcing demands new management skills [1.6mb]
E. Langer, Chimica Oggi / CHEMISTRY TODAY - vol 28 n 4 - July/August 2010 - Bio/pharma outsourcing: Strategic initiative, or just passing off low-end jobs [352k]
E. Langer, Chemical Week; July 2010 - Will Protein A Be the Long-Term Solution for Your Purification Needs? Cost-effective purification technologies.
E. Langer, BioPharm International, June 2010 - As Biopharma Matures: Working Harder, Getting Leaner
E. Langer, Pharmaceutical Manufacturing, April 28, 2010 - Biomanufacturers' Anxieties Over New Downstream Technologies
E. Langer, Biopharm International, April 2010 - Podcast: Focus on Pharma Episode 4: Maturing Biopharma: The Need to Do More with Less
E. Langer, Pharmaceutical Manufacturing, April 28, 2010 - Biopharma Outsourcing Trends: Client-contractor relationships grow more complex
E. Langer, Contract Pharma, April 2010 - Waste Not, Want Not: Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization
E. Langer, Pharmaceutical Technology, April 2, 2010, Vol 34, Issue 4, p. 122-124. - Outsourcing Comes of Age
E. Langer, European Biotech Review, March 2010 - Downstream Processing: Promising Technologies are on the Horizon; Beyond traditional chromatography
E. Langer, BioPharm International, March 2010 - Realistic Expectations Likely to Prevail in 2010: As Economy Recovers, Firms in Sector Remain Cautiously Optimistic about Future Growth
E. Langer, Genetic Engineering News, March 2010 - Contract Manufacturing Bucks Economic Downturn: Practitioners Cite Depth of Experience and Formation of a More Mature and Stable Business Model
E. Langer, Genetic Engineering News, February 2010 - Downstream Factors That Will ContinueTo Constrain Manufacturing Through 2013
E. Langer Bioprocessing Journal, Winter 2009 - Single-Use Technology in Biopharmaceutical
Manufacture, part 1
Brian Lee, Eric Langer, Ran Zheng, Wylie, Book Chapter, February 2010. - A Bio View of Outsourcing: Strategic not tactical considerations are driving decisions in biopharmaceutical outsourcing
E. Langer, Pharmaceutical Technology, February 2010
> 2009
- Licensing of Expression Systems
E. Langer, Biopharm International (December 2009) - Avoiding the Regulatory Catch 22
E. Langer, Biopharm International (August 2009) - On the Horizon: New Expression Systems to Become Common Industry Platforms
E. Langer, Biopharm International (June 2009) - China Increases Healthcare Investment Gov’t Investment Is Opening Up Opportunities for Domestic and Multinational Firms [117K PDF]
Qing Xia and Daming Chen, Genetic Engineering News (June 1, 2009) - Capacity Utilization & Capacity Constraints [275K
PDF]
E. Langer, Contract Pharma (May 2009) - Tracking Downstream Purification: Downstream is viewed as a capacity constraint now, and figures to remain that way. [544K PDF]
E. Langer, Pharmaceutical Manufacturing (April 2009) - Trends in Single-use Bioproduction [243K
PDF]
E. Langer, BioProcess International (April 2009) - Expression Systems Royalties Battle
E. Langer, Biopharm International (April 2009) - Biopharma Faces the Future [544K
PDF]
E. Langer, Pharmaceutical Manufacturing (April 2009) - Expanding Expression: Beyond CHO, E coli and Yeast [207K
PDF]
E. Langer, EBR-European Biopharmaceutical Review (April 2009) - Budgets Shifting in Biopharma Manufacturing [53K
PDF]
E. Langer, Genetic Engineering News (April 15, 2009) - Disposables: A growing throw-away culture[651K
PDF]
E. Langer, Manufacturing Chemist (7 April 2009) - Trends in Capacity Utilization for Therapeutic Monoclonal Antibody Production [525K
PDF]
E. Langer, MABS Journal (March/April 2009) - New Expression Systems Create Opportunities for Innovators, CMOs, and Product Developers
E. Langer, Biopharm International (March 2009) - Crunch Time: Finances, not technologies are shaping the future of biopharma [488K
PDF]
E. Langer, World Pharmaceutical Frontiers (March 2009) - Riding the Dragon Biotechnology in China: Analysis of Future Directions and Growth of Biotechnology in China [374K
PDF]
Qing Vicky XIA, Asia Biotech Directions (2008-2009) - Capitalizing on Novel Expression Systems: Technologies Make Products More Efficiently [112K
PDF]
E. Langer, Genetic Engineering News (January 15, 2009) - Disposables: Current Trends and Analysis [209K
Word]
E. Langer, BioProcess International (January 2009)
> 2008
- Biopharmaceuticals in India: 2008 in Review [48K Word Doc]
E. Langer, Biopharm International (December 2008) - Supplying Biopharma amid a Global Downturn: A passage to India [72K Word Doc]
E. Langer, BioWorld Europe, (December 2008) - Bio-Outsourcing Trends: A new study explores capacity and production issues [84K PDF]
E. Langer, Contract Pharma (Nov/Dec 2008) - Contract Manufacturing in India: Is the CMO Model a Viable Business? [220K PDF]
E. Langer, Biopharm International, (November 2008) - Quantifying Trends Toward Alternatives to Protein A: Survey Results [60K PDF]
E. Langer, BioProcess International, Elucidation, (December 2008) - Critical Issues in Outsourcing to a CMO: Indications of a Maturing Industry [300K PDF]
E. Langer, BioProcess International, (November 2008 Supplement) - Explaining Capacity Expansion [990k PDF]
E. Langer, European Biopharmaceutical Review, (November 2008) - Biomanufacturing Capacity Use, Solid Performance in 2007 [100K PDF]
E. Langer, BioProcess International, (October 2008) - FDA Pushes PAT and Companies Shove Back: Even with Perks, PAT Implementation Remains Stalled [28K PDF]
E. Langer, Genetic Engineering News, (Oct 1 2008) - Biotech Facilities Average Batch Failure Every 40.6 Weeks; Capacity Use, Solid Performance in 2007 [208K PDF]
E. Langer, BioProcess International, (September 2008) - Users Sold on Single-use Systems [44K PDF]
E. Langer, Genetic Engineering News, (September 15, 2008) - Biopharmaceutical Outsourcing Opportunities and Challenges [1.3Mb PDF]
E. Langer, BioOutsourcing Asia-CanBiotech, (October 2008) - Pharmaceutical Distribution in India-Drug Manufacturers struggling to improve fragmented network [#K PDF]
A. Kelkar, E. Langer, Biopharm International (October 2008) - Visible Hand: Indian Government Supports in Biopharmaceutical Industry [164K PDF]
E. Langer, Biopharm International (August 2008) - Batch Failure Rates in Biomanufacturing: Good Training and Equipment Among Solutions [28K PDF]
E. Langer, Genetic Engineering News, (August 2008) - India’s Bioinformatics Industry: An Engine for Global Growth [#K PDF]
E. Langer, Biopharm International (July 2008) - Quantifying Downstream Capacity Crunch-Column Resins Implicated in Woes [136K PDF]
E. Langer, Genetic Engineering News, (July 2008) - Bio-Capacity in 2012: The outlook is bright for CMOs [116K PDF]
E. Langer, Contract Pharma, (May 2008) - Downstream Production Impacts Overall Capacity [700K PDF]
E. Langer, BioWorld Europe, (March 2008) - India’s Clinical Trials Market Accelerates [204K PDF]
F. Kermani, E. Langer, Biopharm International (May 2008) - New Book Demysitifies the World of Clincial Trials [13K PDF]
E. Langer (April 24, 2008) - Understanding India’s New Patent Laws [148K PDF]
E. Langer, Biopharm International (April 1, 2008) - Paucity of Biopharma Approvals Raises Alarm [165K PDF]
R. Rader, Genetic Engineering News (March 15, 2008) - Biologics Regulation in India [213K PDF]
E. Langer, Biopharm International (March 1, 2008) - Top 60 Chinese Biofirms Propel Industry Forward [66K PDF]
E. Zhou, Genetic Engineering News (February 15, 2008) - India’s Biogenerics Industry [124K PDF]
E. Langer, Biopharm International (February 1, 2008) - Biopharmaceuticals in India: A New Era [116K PDF]
E. Langer, Biopharm International (January 1, 2008)
> 2007 and earlier
- China as a Biopharmaceutical Powerhouse: Just a matter of time; Despite serious obstacles, development marches ahead [204K PDF]
E. Langer, Biopharm International (December, 2007) - Life Science and Biotechnology Education in China [228K PDF]
E. Langer, YB Zhou, Biopharma International, p 22 (November 1, 2007) - Biopharmaceutical Exports: Converting China’s pharmaceutical manufacturing capacity [276K PDF]
E. Langer, Biopharm International, p 24 (August 2007) - Next Steps Toward Globalization: China’s service sector expanding to meet the needs of its biopharmaceutical Industry [184K PDF]
E. Langer, YB Zhou, Biopharm International, p 26 (July 2007) - Are Biotechnology Meetings and Symposia Doing the Job? [116K PDF]
E. Langer, Biopharm International, p 66 (July 2007) - Downstream Production Challenges in 2007: Study Indicates Problems May Not Be Resolved Before 2011 [104K PDF]
E. Langer, BioProcess International, Vol. 5, No. 6, pp 22-28 (June 2007) - Biogenerics in China: An Evolving Industry. China’s large domestic market potential and its competence in producing biogenerics driving future direction [176K PDF]
E. Langer Biopharm International, p 26 (June 2007) - Biopharmaceutical Disposables as a Disruptive Future Technology: The potential of single-use technology in bioproduction over the next 10 years. [104K PDF]
Eric Langer, Brandon J. Price, BioPharm International (Jun 1, 2007) - Clinical Trials in China: Is China fulfilling its clinical trials promise? [160K PDF]
F. Kermani, Contract Pharma, p 88 (May 2007) - Intellectual Property Protection in China: Does it Warrant Worry? The recent rise in patent application filings reflects new confidence in the future of patent protection [168K PDF]
E. Langer, Biopharm International, p 20 (May 2007) - Vaccine Development in China; Improvements in China’s regulatory and technology scenarios are creating an optimistic outlook for its vaccine industry [228K PDF]; Part Two [236K PDF]
YB Zhou, Biopharm International, p 30 (April 2007) - Marching into a New Era: China’s transformation into an economic global superpower…in the clinical trial sector too. [32K PDF]
F. Kermani, Good Clinical Practices Journal, p 14 (March 2007) - Outsourcing is key to future pharmaceutical R&D strategy. [#K PDF]
Biopharm International, Faiz Kermani, Eric S. Langer (Mar 1, 2007) - Biopharmaceutical Outsourcing in China: A rapidly Changing Business Environment [44K PDF]
E. Langer, European Business Review, p 120 (Spring 2007) - Managing Biopharmaceutical Manufacturing Capacity in 2007
Changes in Demand and Capacity Projected Through 2011 [104K PDF]
Eric S. Langer, BioProcess International Vol. 5, No. 3: pp 20-26 (March 2007) - GEN China Biopharma Basking in its Spotlight [524K PDF]
YB Zhou, Genetic Engineering News p 60 (March 1 2007) - Biopharmaceutical Industry Trends in China-A Five-year Perspective; Now that China has opened its window to the world, its biopharmaceutical industry will see more opportunities [56K PDF]
YB Zhou, Biopharm International, p 32 (March 2007) - Biopharmaceutical Production Outsourcing Matures: Greater Percentage of Biomanufacturers Contracting Out for Flexibility [376K PDF]
E. Langer, BioProcess International Vol. 5, No. 2: pp 32-37 (March 2007) - Pharmaceutical Distribution in China; The country strives to modernize its distribution logistics as thousands of small companies compete for profits [76K PDF]
YB Zhou, Biopharm International, p 24 (February 2007) - Evaluating Disposables: Single Use Technologies in Biomanufacturing; Live Webcast February 15, 2007 [#K PDF]
E. Langer, Panelist, Biopharm International (Feb. 15, 2007) - Opportunities in Biopharmaceutical Outsourcing to China [#K PDF]
YB Zhou, BioProcess International, p 16 (January 2007) - Defining the Chinese Biopharmaceutical Market; A relatively liberal regulatory environment and huge market potential are leading to rapid industry expansion, Part One [272K PDF] Part Two [164K PDF]
E. Langer, YB Zhou, Biopharm International, p 24 (January 2007) - What China Needs for Success in Biopharmaceutical Manufacturing [#K PDF]
E. Langer, Processing Journal (November 2006) - Biomanufacturing Capacity Flat in 2006: CMOs future in Good Shape [#K PDF]
E. Langer, Contract Pharma (Nov/Dec 2006) - China-grown Pharma Products [#K PDF]
YB Zhou, Genetic Engineering News, p 1 (Nov 15, 2006) - Contract Research in China: A Catalyst for Pharmaceutical Industry Growth
Y Zhou, BioPlan Associates, Inc., Pharmaceutical Manufacturing (October 2006) - Chinese Biogenerics and Protection of IP [628K PDF]
Large Market Potential and Solid Foundation Sets the Stage — Eliza Yibing Zhou, BioPlan Associates, Genetic Engineering News (September 2006) - Contract Research Drives China's Pharma Sector [33K PDF]
Contract research is both a vehicle for Chinese pharmas to expand their R&D expertise and quality levels, and a bridge for them to enter global markets. — Yibing Zhou, BioPlan Associates, PharmaManufacturing.com (August 2006) - Biopharmaceutical Approvals Review [49K PDF]
While 2005 was a Record-Setting Year, 2006 Experiences a Slowdown — Ronald A. Rader, BioPlan Associates, Genetic Engineering News (August 2006) - Biopharma CMOs in China: Will Excess Capacity Drive the Industry? [96K PDF]
Contract Pharma, p 110 (June 2006) - CMOs and the Outsourcing Dilemma [96K PDF]
E. Langer, World Pharmaceutical Frontiers, p 55 (Summer 2006) - Purification Woes Upstage Upstream Gains [#K PDF]
J. Ranck, Genetic Engineering News, p 46 (March 2006) - Capacity Bottleneck Squeezed by Downstream Processes [#K PDF]
E. Langer, J. Ranck, Biopharm International (March 2006) - Bioprocessing: Survey Assesses Biopharmaceutical Manufacturing Capacity Growth [Weblink] or Download PDF [484K PDF]
—Genetic Engineering News (November 2005) - Pharmaceutical Manufacturing [196K PDF]
Biopharma Capacity on the Rise — Paul Thomas, Managing Editor, Pharmaceutical Manufacturing (November 2005) - Disposables Economics: The ROI Case — Economic Justification for Disposables in Biopharmaceutical Manufacturing [223K PDF]
BioProcess International (October 2005)
Subscribe to BioProcess International - International Competitiveness of Biopharmaceutical Manufacturing Hit by Technical Staffing Shortages [175K PDF]
Contract Pharma (February 2004) - Outsourcing Biopharmaceutical Manufacturing [227K PDF]
Genetic Engineering News (January 2004) - Manufacturers Must Cooperate to Compete: The Biomanufacturing Industry Faces a Catch-22 [106K PDF]
Contract Pharma (October, 2002) - Uniting Business and Science[74K PDF]
By Karen Nitkin for The Baltimore Sun (February 25, 2001) - Marketing Technical Products [126K PDF]
> Technical Reports
- Stem Cell Industry Opportunities [Spring 2002]
This report was published in conjunction with MarketResearch.com- Tissue EngineeringAn Industry Assessment [Spring 2001]
This report was published in conjunction with MarketResearch.com- Cell and Tissue Culture Media, Sera, and Reagents
Medical and Healthcare Marketplace Guide Research Reports 2001
- Genomics
Medical and Healthcare Marketplace Guide Research Reports 2001- Laboratory Animals
Medical and Healthcare Marketplace Guide Research Reports 2001- Tissue Engineering
Medical and Healthcare Marketplace Guide Research Reports 2001- Transgenic Animals
Medical and Healthcare Marketplace Guide Research Reports 2001 - Tissue EngineeringAn Industry Assessment [Spring 2001]


